#03 Carolina Oliveira, the founder & CEO of OneSkin Technologies | Skin Aging, OneSkin, and Building a Longevity Company
Live Longer World
00:00
Is There a Skin Specific Peptide That Targets Aging?
Sal: Even if it's 5%, the thing with synths cells, as you mentioned, is that they secrete these inflammatory cytokines and they just, it's like a bad apple affects everything. So after testing over a thousand of peptides, we got to this new peptide OS1 that's able to reduce up to 40, 50 percent the total amount of synths cells. We have tested the models of progeria that's an accelerated aging model. We've tested the model of UVB damages. And then once we treat the cells with this peptide, we can measure, you know, through beta-galactoside days or through other markers. And we can
Transcript
Play full episode
